DIA
ALXA

Denver Investment Advisors’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Denver Investment Advisors’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-20,808
Closed -$95K – 652
2014
Q2 		$95K Hold
20,808
– – ﹤0.01% 604
2014
Q1 		$92K Buy
20,808
+7,122
+52% +$36.5K ﹤0.01% 601
2013
Q4 		$65 Hold
13,686
– – ﹤0.01% 570
2013
Q3 		$70K Buy
+13,686
New +$64.4K ﹤0.01% 577

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return

Denver Investment Advisors's ALXA Position: Q3 2014 in Review

Denver Investment Advisors sold out of Alexza Pharmaceuticals Inc (ALXA) in Q3 2014, closing a stake of 20,808 shares — an estimated $95K sold.

Denver Investment Advisors first reported a position in ALXA in Q3 2013 and held it in 4 quarters. The position peaked at $95K in Q2 2014. 38 funds tracked by Wall St. Rank hold ALXA as of Q3 2014.

  • Denver Investment Advisors reported no remaining Alexza Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Denver Investment Advisors sold 20,808 Alexza Pharmaceuticals Inc shares in Q3 2014, an estimated $95K.
  • Denver Investment Advisors first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 4 quarters.
  • Denver Investment Advisors's Alexza Pharmaceuticals Inc position peaked at $95K in Q2 2014.
  • 38 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q3 2014.

Based on Denver Investment Advisors's 13F filing for Q3 2014, filed 13 Nov 2014.